Progranulin Oncogenic Network in Solid Tumors

Progranulin is a pleiotropic growth factor with important physiological roles in embryogenesis and maintenance of adult tissue homeostasis. While-progranulin deficiency is associated with a broad range of pathological conditions affecting the brain, such as frontotemporal dementia and neuronal ceroi...

Full description

Bibliographic Details
Main Authors: Elisa Ventura, Giacomo Ducci, Reyes Benot Dominguez, Valentina Ruggiero, Antonino Belfiore, Elena Sacco, Marco Vanoni, Renato V. Iozzo, Antonio Giordano, Andrea Morrione
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/6/1706
_version_ 1797612960144687104
author Elisa Ventura
Giacomo Ducci
Reyes Benot Dominguez
Valentina Ruggiero
Antonino Belfiore
Elena Sacco
Marco Vanoni
Renato V. Iozzo
Antonio Giordano
Andrea Morrione
author_facet Elisa Ventura
Giacomo Ducci
Reyes Benot Dominguez
Valentina Ruggiero
Antonino Belfiore
Elena Sacco
Marco Vanoni
Renato V. Iozzo
Antonio Giordano
Andrea Morrione
author_sort Elisa Ventura
collection DOAJ
description Progranulin is a pleiotropic growth factor with important physiological roles in embryogenesis and maintenance of adult tissue homeostasis. While-progranulin deficiency is associated with a broad range of pathological conditions affecting the brain, such as frontotemporal dementia and neuronal ceroid lipofuscinosis, progranulin upregulation characterizes many tumors, including brain tumors, multiple myeloma, leiomyosarcoma, mesothelioma and epithelial cancers such as ovarian, liver, breast, bladder, adrenal, prostate and kidney carcinomas. The increase of progranulin levels in tumors might have diagnostic and prognostic significance. In cancer, progranulin has a pro-tumorigenic role by promoting cancer cell proliferation, migration, invasiveness, anchorage-independent growth and resistance to chemotherapy. In addition, progranulin regulates the tumor microenvironment, affects the function of cancer-associated fibroblasts, and modulates tumor immune surveillance. However, the molecular mechanisms of progranulin oncogenic function are not fully elucidated. In bladder cancer, progranulin action relies on the activation of its functional signaling receptor EphA2. Notably, more recent data suggest that progranulin can also modulate a functional crosstalk between multiple receptor-tyrosine kinases, demonstrating a more complex and context-dependent role of progranulin in cancer. Here, we will review what is currently known about the function of progranulin in tumors, with a focus on its molecular mechanisms of action and regulation.
first_indexed 2024-03-11T06:49:14Z
format Article
id doaj.art-0b3fcf7f3c184db485c767df05a7384f
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T06:49:14Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-0b3fcf7f3c184db485c767df05a7384f2023-11-17T10:06:04ZengMDPI AGCancers2072-66942023-03-01156170610.3390/cancers15061706Progranulin Oncogenic Network in Solid TumorsElisa Ventura0Giacomo Ducci1Reyes Benot Dominguez2Valentina Ruggiero3Antonino Belfiore4Elena Sacco5Marco Vanoni6Renato V. Iozzo7Antonio Giordano8Andrea Morrione9Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USASbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USASbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USASbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USADepartment of Clinical and Experimental Medicine, Endocrinology Unit, University of Catania, Garibaldi-Nesima Hospital, 95122 Catania, ItalyDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milan, ItalyDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milan, ItalyDepartment of Pathology, Anatomy and Cell Biology, Translational Cellular Oncology Program, Sidney Kimmel Cancer Center, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USASbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USASbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USAProgranulin is a pleiotropic growth factor with important physiological roles in embryogenesis and maintenance of adult tissue homeostasis. While-progranulin deficiency is associated with a broad range of pathological conditions affecting the brain, such as frontotemporal dementia and neuronal ceroid lipofuscinosis, progranulin upregulation characterizes many tumors, including brain tumors, multiple myeloma, leiomyosarcoma, mesothelioma and epithelial cancers such as ovarian, liver, breast, bladder, adrenal, prostate and kidney carcinomas. The increase of progranulin levels in tumors might have diagnostic and prognostic significance. In cancer, progranulin has a pro-tumorigenic role by promoting cancer cell proliferation, migration, invasiveness, anchorage-independent growth and resistance to chemotherapy. In addition, progranulin regulates the tumor microenvironment, affects the function of cancer-associated fibroblasts, and modulates tumor immune surveillance. However, the molecular mechanisms of progranulin oncogenic function are not fully elucidated. In bladder cancer, progranulin action relies on the activation of its functional signaling receptor EphA2. Notably, more recent data suggest that progranulin can also modulate a functional crosstalk between multiple receptor-tyrosine kinases, demonstrating a more complex and context-dependent role of progranulin in cancer. Here, we will review what is currently known about the function of progranulin in tumors, with a focus on its molecular mechanisms of action and regulation.https://www.mdpi.com/2072-6694/15/6/1706progranulinsolid tumorsRTKs
spellingShingle Elisa Ventura
Giacomo Ducci
Reyes Benot Dominguez
Valentina Ruggiero
Antonino Belfiore
Elena Sacco
Marco Vanoni
Renato V. Iozzo
Antonio Giordano
Andrea Morrione
Progranulin Oncogenic Network in Solid Tumors
Cancers
progranulin
solid tumors
RTKs
title Progranulin Oncogenic Network in Solid Tumors
title_full Progranulin Oncogenic Network in Solid Tumors
title_fullStr Progranulin Oncogenic Network in Solid Tumors
title_full_unstemmed Progranulin Oncogenic Network in Solid Tumors
title_short Progranulin Oncogenic Network in Solid Tumors
title_sort progranulin oncogenic network in solid tumors
topic progranulin
solid tumors
RTKs
url https://www.mdpi.com/2072-6694/15/6/1706
work_keys_str_mv AT elisaventura progranulinoncogenicnetworkinsolidtumors
AT giacomoducci progranulinoncogenicnetworkinsolidtumors
AT reyesbenotdominguez progranulinoncogenicnetworkinsolidtumors
AT valentinaruggiero progranulinoncogenicnetworkinsolidtumors
AT antoninobelfiore progranulinoncogenicnetworkinsolidtumors
AT elenasacco progranulinoncogenicnetworkinsolidtumors
AT marcovanoni progranulinoncogenicnetworkinsolidtumors
AT renatoviozzo progranulinoncogenicnetworkinsolidtumors
AT antoniogiordano progranulinoncogenicnetworkinsolidtumors
AT andreamorrione progranulinoncogenicnetworkinsolidtumors